Rockwell Medical Inc

NASDAQ RMTI

Data sourced from

and

Daily

Download Data

Rockwell Medical Inc Price to Sales Ratio (P/S) on June 03, 2024: 0.61

Rockwell Medical Inc Price to Sales Ratio (P/S) is 0.61 on June 03, 2024, a -44.14% change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.

Rockwell Medical Inc 52-week high Price to Sales Ratio (P/S) is 727.64 on August 11, 2023, which is 118,703.03% above the current Price to Sales Ratio (P/S).
Rockwell Medical Inc 52-week low Price to Sales Ratio (P/S) is 0.00 on March 18, 2024, which is -99.91% below the current Price to Sales Ratio (P/S).
Rockwell Medical Inc average Price to Sales Ratio (P/S) for the last 52 weeks is 3.53.

NASDAQ: RMTI

Rockwell Medical Inc

CEO	Dr. Mark Strobeck Ph.D.
IPO Date	Jan. 27, 1998
Location	United States
Headquarters	30142 South Wixom road, Wixom, MI, United States, 48393
Employees	237
Sector	Healthcare
Industry	Drug manufacturers - specialty & generic

Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Key trends